Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Imagin Medical's share price for the quarter that ended in Jun. 2023 was $0.0749. Imagin Medical's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 10.83 Mil. Therefore, Imagin Medical's market cap for the quarter that ended in Jun. 2023 was $0.81 Mil.
Imagin Medical's quarterly market cap
declined
from Dec. 2022 ($2.12 Mil) to Mar. 2023 ($1.55 Mil) and
declined
from Mar. 2023 ($1.55 Mil) to Jun. 2023 ($0.81 Mil).
Imagin Medical's annual market cap
declined
from Sep. 2020 ($3.46 Mil) to Sep. 2021 ($3.43 Mil) and
declined
from Sep. 2021 ($3.43 Mil) to Sep. 2022 ($2.17 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Imagin Medical's Enterprise Value for Today is $0.00 Mil.
Imagin Medical (OTCPK:IMEXF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Imagin Medical Market Cap Related Terms
Imagin Medical Market Cap Historical Data
* Premium members only.
The historical data trend for Imagin Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Imagin Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Imagin Medical Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Imagin Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where Imagin Medical's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Imagin Medical's Market Cap for the fiscal year that ended in Sep. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Imagin Medical (IMEXF) has a Market Cap of $0.00 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Imagin Medical and its competitors.
Is Imagin Medical's Market Cap too high?
Imagin Medical's current Market Cap is $0.00 Mil.
How does Imagin Medical's Market Cap compare to ABT and SYK?
Imagin Medical's Market Cap of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. The industry median Market Cap is 121.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.29, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Imagin Medical and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imagin Medical's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imagin Medical stock overvalued right now?
Imagin Medical (IMEXF) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Imagin Medical (IMEXF), the current Market Cap is $0.00 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Imagin Medical Inc is a Urologic Oncology company developing technologies to visualize and treat urologic cancers, including bladder and prostate cancer, through minimally invasive surgery. The company's first product, the i/Blue Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting bladder cancer, helping to improve the surgical management of this disease. Imagin's follow-on product, the enCAGE Coil is a device with 510(k) clearance for soft tissue ablation. Imagin intends to refine the disposable bipolar radio frequency-based probe for use in the treatment of prostate cancer and benign prostate hypoplasia (BPH) and submit appropriate FDA premarket applications for the new indications.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IMEXF has been successfully added to your 